<http://schema.org/url>
<http://www.fiercebiotech.com/press-releases/astrazeneca-announces-top-line-results-oskira-4-phase-iib-study-fostamatini>
<http://www.fiercebiotech.com/press-releases/astrazeneca-announces-top-line-results-oskira-4-phase-iib-study-fostamatini>